Serum glycoproteins in coronary artery disease. | Zendy

S W Snyder | Zendy; Eugene L. Coodley | Zendy; Beatrice C. Durham | Zendy; Ronald S. Pennock | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Serum glycoproteins in coronary artery disease.

Author(s) -

S W Snyder,

Eugene L. Coodley,

Beatrice C. Durham,

Ronald S. Pennock

Publication year - 1977

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/01.cir.56.3.359

Subject(s) - glycoprotein , medicine , transferrin , haptoglobin , coronary artery disease , orosomucoid , cardiology , biochemistry , biology

Serum glycoprotein levels were compared in two groups of age- and sex-matched patients, 15 with coronary artery disease and 14 normal controls. While total glycoprotein levels were increased in the coronary group, significantly higher levels were found in only five of 16 glycoproteins--C3c haptoglobin, GC-globulin, alpha1-acid glycoprotein, and C3 activator--with no change in 10 other glycoproteins and significant decrease in transferrin. This study demonstrates what appears to be a glycoprotein profile in coronary artery disease and reviews possible interactions of glycoproteins with known risk factors in atherogenesis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research